Avicor Ltd. is a company that develops products and provides services for the identification of drug and drug target candidates in the very early phase of drug development.
Avicor fills a gap between chemistry and genomics with socalled chemical microarrays. This technology makes it possible to screen tens of thousands of drug-like molecules in hours for their interaction with a drug target without the need for preestablished and optimized screens. The same platform can be used for differential proteome screening for the identification of new disease targets.